No Photo Available

Last Update

2017-02-03T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Rick Winningham?

Mr. Rick E. Winningham

Chief Executive Officer

Theravance , Inc.

Direct Phone: (650) ***-****       

Email: r***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Theravance , Inc.

901 Gateway Blvd.

South San Francisco, California 94080

United States

Company Description

Theravance Biopharma is a diversified biopharmaceutical company with the core purpose of creating medicines that help improve lives of patients suffering from serious illness. Our pipeline of internally discovered product candidates includes potential bes ... more

Find other employees at this company (458)

Background Information

Employment History

Advanced Medicine

Various Management Positions

Bristol-Myers Squibb Company

Affiliations

Board Member
OncoMed Pharmaceuticals Inc

Member of the External Advisory Board
College of Business and Administration at Southern Illinois University

Member of the External Advisory Board
Business Hall of Fame

Member, Jazz Board
Auxilium Pharmaceuticals , Inc.

Board Member
Biographies

Member, Jazz Board
Catalyst Advisors LLC

Board Member
Jazz Pharmaceuticals plc

Board Member
California Healthcare Institute Inc

Board Member
Biotechnology Industry Organization

Education

Arthur High School

B.S.

Southern Illinois University

M.B.A.

Texas Christian

M.B.A.

Texas Christian University

bachelor's degree

finance

SIUC's College of Education

Web References (198 Total References)


...

www.sec.gov [cached]

0001302443 Winningham Rick E C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Chief Executive Officer


Upon the recommendation of our ...

www.sec.gov [cached]

Upon the recommendation of our nominating/corporate governance committee, our board of directors has nominated Rick E Winningham, Robert V. Gunderson, Jr., Susan M. Molineaux, Ph.D. and Donal O'Connor, each a current Class II director, for election as Class II directors.

...
Rick E Winningham
...
Rick E Winningham has served as Chairman of the board of directors since July 2013. He has served as our Chief Executive Officer since our spin-off from Theravance, Inc. (renamed Innoviva, Inc. in January 2016) in June 2014. From October 2001 to August 2014, Mr. Winningham served as Chief Executive Officer of Theravance, Inc., where he also served as Chairman of the board of directors from April 2010 to October 2014. From 1997 to 2001 he served as President, Bristol Myers Squibb Oncology/Immunology/Oncology Therapeutics Network (OTN) and also as President of Global Marketing from 2000 to 2001.
...
responsibility for U.S. Oncology/Immunology/OTN at Bristol Myers Squibb, Mr. Winningham also had full responsibility for Global Marketing in the Cardiovascular, Infectious Disease, Immunology, Oncology/Metabolics and GU/GI/Neuroscience therapeutic areas. Over a fifteen-year period beginning in 1986 with BMS and its predecessor, Bristol-Myers, Mr. Winningham held various U.S. and global management positions. Mr. Winningham served as a Director on the board of directors of the California Healthcare Institute ("CHI") from November 2011 to March 2015. He was elected Chairman of CHI in January 2014, a position he held until CHI merged with Baybio to become the California Life Sciences Association ("CLSA") in March 2015. Mr. Winningham was subsequently elected to the role of Chairman of CLSA in March 2015. He stepped down from the CLSA position in November 2015. He is a member of the board of directors of Jazz Pharmaceuticals plc, and a member of the board of directors of OncoMed Pharmaceuticals, Inc. Mr. Winningham is also a past member of Biotechnology Industry Organization's board of directors and served on the Health Section Governing Board Standing Committee on Reimbursement. Mr. Winningham holds an M.B.A. from Texas Christian University and a B.S. degree from Southern Illinois University. We believe that it is appropriate and desirable for our Chief Executive Officer to serve on our board of directors. Mr. Winningham's demonstrated leadership in his field, his prior senior management experience in our industry and his experience as our Chief Executive Officer contributed to our conclusion that he should serve as a director.
...
In his role as lead independent director, Mr. Young provides a source of leadership for the board of directors that is complementary to that of Mr. Winningham as chairman of the board of directors.
...
In addition, given the relatively small size of our company, our board of directors believes that Mr. Winningham's leadership as both chairman and chief executive officer is appropriate. Our Board of Directors Guidelines on Significant Corporate Governance Issues ("Corporate Governance Guidelines") are posted on the Investor Relations portion of our website at www.theravance.com.
...
Mr. Winningham, our principal executive officer, does not participate in the determination of his own compensation or the compensation of our directors. However, he makes recommendations to our compensation committee regarding the amount and form of the compensation of the other executive officers and any key employees, and he often participates in the committee's deliberations about their compensation.
...
Rick E Winningham
...
Rick E Winningham.


Theravance Biopharma, Inc.: Management Team

investor.theravance.com [cached]

Rick E Winningham Chairman and Chief Executive Officer

Rick E Winningham has served as Chief Executive Officer and Chairman of the Board of Directors of Theravance Biopharma since its spin-off from Theravance, Inc. in June 2014. From October 2001 to August 2014, Mr. Winningham served as Chief Executive Officer of Theravance, Inc., where he also served as Chairman of the Board of Directors from April 2010 to October 2014. Prior to joining Theravance, Inc., he served as President, Bristol-Myers Squibb (BMS) Oncology/Immunology/Oncology Therapeutics Network (OTN) from 1997 to 2001, and also as President of Global Marketing from 2000 to 2001. In addition to operating responsibility for U.S. Oncology/Immunology/OTN, Mr. Winningham also had full responsibility for Global Marketing in the Cardiovascular, Infectious Disease, Immunology, Oncology/Metabolics and GU/GI/Neuroscience therapeutic areas. Over a fifteen-year period with BMS and its predecessor, Bristol-Myers, Mr. Winningham held various U.S. and global management positions. During his tenure with BMS, he was associated with the development and commercialization of several major pharmaceutical products, such as Taxol®, Paraplatin®, Zerit®, Videx®, Reyataz®, and Abilify®.
Mr. Winningham holds an M.B.A. from Texas Christian University and a B.S. from Southern Illinois University. He is a Director on the Board of the California Life Sciences Association (CLSA). Previously, Mr. Winningham served as a Director on the Board of the California Healthcare Institute (CHI) from November 2011 to March 2015. He was elected Chairman of CHI in January 2014, a position he held until CHI merged with BayBio to become CLSA in March 2015. Mr. Winningham was subsequently elected to the role of Chairman of CLSA in March 2015. He stepped down from the position in November 2015. He is a member of the Board of Directors of Jazz Pharmaceuticals, and a member of the Board of Directors of OncoMed Pharmaceuticals, Inc. Mr. Winningham is also a past member of Biotechnology Industry Organization's Board of Directors and served on the Health Section Governing Board Standing Committee on Reimbursement.


Theravance, Inc. and Theravance Biopharma, Inc. Announce Completion of Separation of Late-Stage Partnered Respiratory Assets From Biopharmaceutical Operations (NASDAQ:TBPH)

investor.theravance.com [cached]

"Now that we have completed the separation, each company will focus its efforts on building value by unlocking unique and promising opportunities," said Rick E Winningham, Chief Executive Officer of both

...
Rick Winningham
...
Rick E Winningham 650-808-4045 investor.relations@theravance.com


This is evidenced not only by ...

www.biotechnologyevents.com [cached]

This is evidenced not only by today's sNDA milestone but also our ongoing Phase 3 registrational study of telavancin in Staphylococcus aureus bacteremia," said Rick E Winningham, Chairman and Chief Executive Officer of Theravance Biopharma.

Similar Profiles

Other People with this Name

Other people with the name Winningham

Janet Winningham
Honigman Miller Schwartz and Cohn LLP

Jason Winningham
CB Richard Ellis Inc

Pete Winningham
Heidrick & Struggles International Inc

Rob Winningham
Monterey Public Library

Allison Winningham
rue21, inc.

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory